Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

David Simpson to Muscle, Skeletal

This is a "connection" page, showing publications David Simpson has written about Muscle, Skeletal.

 
Connection Strength
 
 
 
0.674
 
  1. Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 06; 70(19):1691-8.
    View in: PubMed
    Score: 0.160
  2. Amirali A, Mu L, Gracies JM, Simpson DM. Anatomical localization of motor endplate bands in the human biceps brachii. J Clin Neuromuscul Dis. 2007 Dec; 9(2):306-12.
    View in: PubMed
    Score: 0.155
  3. O'Dell MW, Brashear A, Jech R, Lejeune T, Marque P, Bensmail D, Ayyoub Z, Simpson DM, Volteau M, Vilain C, Picaut P, Gracies JM. Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study. PM R. 2018 01; 10(1):1-10.
    View in: PubMed
    Score: 0.075
  4. Thomas AM, Simpson DM. Contralateral weakness following botulinum toxin for poststroke spasticity. Muscle Nerve. 2012 Sep; 46(3):443-8.
    View in: PubMed
    Score: 0.054
  5. Robinson-Papp J, Tan IL, Simpson DM. Neuromuscular complications in HIV: effects of aging. J Neurovirol. 2012 Aug; 18(4):331-8.
    View in: PubMed
    Score: 0.052
  6. Simpson DM, Gracies JM, Graham K, Hallett M, Miyasaki J, Naumann M, Russman B, Simpson L, So Y. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology. 2009 Sep 01; 73(9):736-7; author reply 737-8.
    View in: PubMed
    Score: 0.044
  7. Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 06; 70(19):1699-706.
    View in: PubMed
    Score: 0.040
  8. Harvey L, Simpson D, Glinsky J, Pirronello D, McLean S. Quantifying the passive extensibility of the flexor pollicis longus muscle in people with tetraplegia. Spinal Cord. 2005 Oct; 43(10):620-4.
    View in: PubMed
    Score: 0.033
  9. Verma S, Micsa E, Estanislao L, Simpson D. Neuromuscular complications in HIV. Curr Neurol Neurosci Rep. 2004 Jan; 4(1):62-7.
    View in: PubMed
    Score: 0.030
  10. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology. 1996 May; 46(5):1306-10.
    View in: PubMed
    Score: 0.017
  11. Vinti M, Costantino F, Bayle N, Simpson DM, Weisz DJ, Gracies JM. Spastic cocontraction in hemiparesis: effects of botulinum toxin. Muscle Nerve. 2012 Dec; 46(6):926-31.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)